Progression of atypical parkinsonian syndromes: PROSPECT-M-UK study implications for clinical trials

The advent of clinical trials of disease-modifying agents for neurodegenerative disease highlights the need for evidence-based end point selection. Here we report the longitudinal PROSPECT-M-UK study of progressive supranuclear palsy (PSP), corticobasal syndrome (CBS), multiple system atrophy (MSA)...

Descripción completa

Detalles Bibliográficos
Autores principales: Street, Duncan, Jabbari, Edwin, Costantini, Alyssa, Jones, P Simon, Holland, Negin, Rittman, Timothy, Jensen, Marte T, Chelban, Viorica, Goh, Yen Y, Guo, Tong, Heslegrave, Amanda J, Roncaroli, Federico, Klein, Johannes C, Ansorge, Olaf, Allinson, Kieren S J, Jaunmuktane, Zane, Revesz, Tamas, Warner, Thomas T, Lees, Andrew J, Zetterberg, Henrik, Russell, Lucy L, Bocchetta, Martina, Rohrer, Jonathan D, Burn, David J, Pavese, Nicola, Gerhard, Alexander, Kobylecki, Christopher, Leigh, P Nigel, Church, Alistair, Hu, Michele T M, Houlden, Henry, Morris, Huw, Rowe, James B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393398/
https://www.ncbi.nlm.nih.gov/pubmed/36975168
http://dx.doi.org/10.1093/brain/awad105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393398/
https://www.ncbi.nlm.nih.gov/pubmed/36975168
http://dx.doi.org/10.1093/brain/awad105

Ejemplares similares